Multikinase inhibition-mediated proliferative vitreoretinopathy therapy by nanoparticles in rabbits.
Our study has provided preclinical support for a liposomal formulation containing NTB that, with single-dose administration, has the potential to be effective in vivo in preventing the development of PVR and its correlated pathologies without causing any significant side effects.
Authors
- Sevda Müftüoğlu (ORCID: https://orcid.org/0000-0003-0664-0204)
- Çetin Taş (ORCID: https://orcid.org/0000-0001-9004-3239)
- Burcu Üner (ORCID: https://orcid.org/0000-0003-4691-0432)
- Elif Acar Arslan (ORCID: https://orcid.org/0000-0002-3284-107X)
- Faruk Öztürk (ORCID: https://orcid.org/0000-0003-4819-4505)
- Serkan Tureli
Institutions
- Istanbul Kent University (TR)
- Ulucanlar Göz Eğitim ve Araştırma Hastanesi (TR)
- Hacettepe University (TR)
Publication Details
- Journal
- PubMed
- Published
- 2025-01-01
- Primary Topic
- Retinal and Macular Surgery
- Type
- article
- Field-Weighted Citation Impact
- 0.00